Changes in the Phagocytic Cells in Children Treated with Continuous Ambulatory Peritoneal Dialysis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 2-3, 1997, Pages 189-194

  Wa̧sik, Maria ^a   Blaim, Maria ^a   Kolewska, Danuta ^a   Janota Krawczyk, Ewelina ^a   Tomaszewska Pańczyk, Małgorzata ^a   Sieniawska, Maria ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Blood neutrophils; Marcophages; Peritoneal dialysis; Phagocytosis

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; FC RECEPTOR; MICROSPHERE;

ADOLESCENT; ARTICLE; BLOOD; CHILD; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; NEUTROPHIL; PATHOLOGY; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PERITONITIS; PHAGOCYTOSIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; UREMIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MACROPHAGES, PERITONEAL; MALE; MICROSPHERES; NEUTROPHILS; PERITONEAL CAVITY; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PHAGOCYTOSIS; PROSPECTIVE STUDIES; RECEPTORS, COMPLEMENT 3B; RECEPTORS, IGG; STAPHYLOCOCCUS AUREUS; UREMIA;

EID: 0031324390     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ABRAMSON J. S., WHEELER J. G. and QUIE P. G. (1985): The polymorphonuclear phagocytyc system. In STONE J.: Dermatologic immunology and allergy. c.v. Mosby Co., St. Louis, 68 - 80.
2. ALEXIEWICZ J., SMOGORZEWSKI M., FADDA G. Z. and MASSRY S. G. (1991): Impaired phagocytosis in dialysis patients: Studies on mechanisms. Am. J. Nephrol., 11, 102 - 111.
3. ALOBAIDI H. M., COLES G. A., DAVIES M. and LLOYD D. (1986): Host defense in continuous ambulatory peritoneal dialysis. The effect of the dialysate on phagocyte function. Nephrol. Dial. Transplant., 1, 16 - 21.
4. BERGER M., O'SHEA J., CROSS A. S., FOLKS T. M., CHUSED T. M., BROWN E. J. and FRANK M. M. (1984): Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J. Clin. Invest., 74, 1566 - 1571.
5. BOENISCH T., FARMILO A. J. and STEAD R. H. (1989): Handbook immunochemical staining methods. Dako Co., Carpinteria, California, 13 - 18.
6. HASUI M., HIRABAYASHI Y., HATTORI K. and KOBAYASHI Y. (1991): Increased phagocytic activity of polymorphonuclear leukocytes of chronic granulomatous disease as determined with flow cytometric assay. J. Lab. Clin. Med., 117, 291 - 298.
7. KASHEM A., ENDOH M., NOMOTO Y., SAKAI H. and NAKAZAWA H. (1994): FcR expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy. Kidney Int., 45, 868 - 875.
8. LIN Ch. Y., Ku W. L. and HUANG T. P. (1990): Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am. J. Nephrol., 10, 368 - 373.
9. MURRAY H. W. and COHN Z. A. (1980): Monoclear phagocyte antimicrobial and antitumor activity: The role of oxygen intermedietes. J. Invest. Dermatol., 74, 285 - 288.
10. PETRONI K. C., SHEN L. and GUYRE P. M. (1988): Modulation of human polymorphonuclear leukocyte IgG Fc and Fc receptors mediated functions by IFN-gamma and glucocorticoids. J Immunol., 140, 3467 - 3472.
11. RUIZ P., GOMEZ F. and SCHREIBER A. D. (1990): Impaired function of macrophage Fc receptors in end-stage renal disease. N. Engl. J. Med., 322, 717 - 722.
12. SOUTHWICK F. S. and STOSSEL T. P. (1980): Phagocytosis. In ROSE J. and NOEL R.: American Society for Microbiology. Manual of clinical laboratory immunology, 3rd edition, Washington, DC, 326 - 331.
13. SULOWICZ W., HANICKI Z., URACZ W., HAJTO B., RUGGIERO I. and ZEMBALA M. (1992): Effect of peritoneal macrophages from intermittent peritoneal dialysis patients on lymphocytes in culture. Perit. Dial. Int., 12, 234 - 239.
14. TSAKOLOS N. D., THEOHARIDES Th. C., HENDLER E. D., GOFFINET J., DWYER J. M., WHISLER R. L. and ASKENASE P. W. (1986): Immune defects in chrònic renal impairment: evidence for defective regulation of lymphocyte response by macrophages from patients with chronic renal impairement on haemodialysis. Clin. Exp. Immunol., 63, 218 - 227.